Search Results - Diana L Mandelker
- Showing 1 - 3 results of 3
-
1
Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer by Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana L. Mandelker, Karen Cadoo, Roisin E. O'Cearbhaill
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas by Fionnuala Crowley, Karen A. Cadoo, Sarah Chiang, Diana L. Mandelker, Raazi Bajwa, Alexia Iasonos, Qin C. Zhou, Kathryn M. Miller, Martee L. Hensley, Roisin E. O'Cearbhaill
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics by Andrew M Quinn, Veronica E Klepeis, Diana L Mandelker, Mia Y Platt, Luigi K F Rao, Gregory Riedlinger, Jason M Baron, Victor Brodsky, Ji Yeon Kim, William Lane, Roy E Lee, Bruce P Levy, David S McClintock, Bruce A Beckwith, Frank C Kuo, John R Gilbertson
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book